Basic Information
Medsenic, established in 2010, is a biopharmaceutical start-up company committed to exploring new possibilities offered by the therapeutic uses of arsenic trioxide (As2O3) and providing treatments for patients with autoimmune diseases through this approach.
Medsenic SAS
Paris,Ile-de-France,France
less than 15 people
January 01, 2010
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios